Accuray Inc (NQ: ARAY )
5.080 USD +0.140 (+2.83%) Official Closing Price Updated: 5:15 PM EST, Mar 5, 2021 Add to My Watchlist
Press releases about Accuray Inc
Accuray Reports Fiscal 2020 Second Quarter Financial Results
January 28, 2020
Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2020 ended December 31, 2019.
Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2019 on Tuesday, January 28, 2020 after the market close. Management will host a conference call to...
Accuray To Discuss Revenue Growth Expectations for the Next Three Fiscal Years at the JP Morgan Healthcare Conference
January 13, 2020
Accuray CyberKnife® System Provides Excellent Disease Control for Men with Recurrent Prostate Cancer, a Medical Condition with Few Viable Treatment Options
January 08, 2020
Accuray Incorporated (NASDAQ: ARAY) announced today data from a prospective study which showed that at five years, stereotactic body radiation therapy (SBRT) administered with the CyberKnife® System...
Accuray to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 15, 2020
January 06, 2020
Accuray Incorporated (Nasdaq: ARAY), announced today that Joshua H. Levine, president and chief executive officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday,...
Timpanogos Cancer Services First in Utah to Offer Precise and Accurate Radiation Treatments with the Accuray Radixact® System
December 12, 2019
System is Designed to Improve Treatment Results, Minimize Treatment Impact on Patients' Quality of Life
Stanford University Medical Center to Acquire Second Accuray CyberKnife® M6™ System
December 04, 2019
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Suzanne Winter, the company's new Senior Vice President, Chief Commercial...
Accuray Reports Fiscal 2020 First Quarter Financial Results
October 29, 2019
Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2020 ended September 30, 2019.
Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in the Asia-Pacific region to clinically use the combination of RaySearch's treatment planning system...
Accuray Incorporated (NASDAQ: ARAY) – Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in the Asia-Pacific region to clinically use the combination of...
Accuray Incorporated (Nasdaq: ARAY) announced today that Suzanne Winter has joined the company as Senior Vice President, Chief Commercial Officer effective October 21, 2019. Ms. Winter will have global...
Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2019 on Tuesday, October 29, 2019 after the market close. Management will host a conference call to...
Accuray Educates Radiation Oncology Practices on the Potential Impact of the Proposed Alternative Payment Model (RO-APM)
September 19, 2019
Accuray Incorporated (NASDAQ: ARAY) today published an informational guide designed to help radiation oncology practices understand the complexities of the much-anticipated proposed Medicare & Medicaid...
Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity (Grade 2 or Higher) Than Patients Treated on a Conventional Linear
September 17, 2019
Accuray Incorporated (NASDAQ: ARAY) announces that The Lancet Oncology, a high impact and leading global peer-reviewed oncology journal, has published patient- and clinician-reported outcomes data from...
China Announces Tariff Exclusion for Medical Linear Accelerators
September 16, 2019
Accuray Incorporated (NASDAQ: ARAY) announced that, on September 11, 2019, China's Customs Tariff Commission of the State Council issued a tariff exemption for medical linear accelerators. The tariff...
Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors
September 12, 2019
Accuray Incorporated (NASDAQ: ARAY) strengthened its Board of Directors with the appointment of James (Jim) M. Hindman, effective as of September 6, 2019, and expanding the company's Board to nine...
Geisinger Medical Center is First in Pennsylvania to Treat Cancer Patients with Accuray Radixact® System
September 10, 2019
Leading Health Services Organization Hospital Selected the New Radiation Therapy Device to Expand Its Clinical Capabilities and Provide Treatment Options for a Wider Range of Patients
Accuray to Set ASTRO 2019 in Motion with Patient-first Cancer Treatment Innovations
September 05, 2019
Accuray Incorporated (NASDAQ: ARAY) announced today that it will showcase its industry-leading motion-synchronization cancer treatment technologies at the upcoming American Society for Radiation...
Accuray to Host ASTRO Investor Meeting on September 16, 2019
September 04, 2019
Froedtert & the Medical College of Wisconsin Cancer Network is First in the World to Treat Cancer Patient Using the Accuray Radixact® System with Synchrony® Motion Tracking and Correction Technology
August 21, 2019
Advanced Radiation Therapy Delivery System and Intrafraction Motion Synchronization Functionality Enable Precise, Efficient Treatment of a 45-Year-Old Man with Lung Cancer
Accuray Reports Fourth Quarter and Fiscal 2019 Financial Results
August 15, 2019
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2019.
New Data Demonstrating Benefits of Accuray Software Solutions Presented at the Annual Meeting of the American Association of Physicists in Medicine
July 24, 2019
Accuray Incorporated (NASDAQ: ARAY) announced today that studies validating the benefits of CyberKnife® and Radixact® System software innovations were shared by prominent physicists at the recent 61st...
Accuray Incorporated (NASDAQ: ARAY) today provided an update on the operational progress of its China joint venture, CNNC Accuray (Tianjin) Medical Technology Co., Ltd (CNNC Accuray). CNNC Accuray has...
Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019
July 19, 2019
Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2019 ended June 30, 2019 on Thursday, August 15, 2019 after the market close. Management will host a...
Swiss Medical Network Advances Cancer Care in Switzerland with Multi-System Agreement for Accuray Radiation Therapy Systems and RaySearch Oncology Software Systems
July 18, 2019
New Research Coverage Highlights Accuray, Reinsurance Group of America, GSV Capital, and ANGI Homeservices — Consolidated Revenues, Company Growth, and Expectations for 2019
May 02, 2019
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Accuray Incorporated...
Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology for the Accuray Radixact® System
May 01, 2019
Hospital is the First in Asia to Procure Synchrony for Radixact, Furthering Its Goal to Use Advanced Medical Technology to Improve Cancer Treatments
Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System
April 24, 2019
Only Radiotherapy System with Helical Delivery Capability and Intrafraction Motion Synchronization Functionality, Offering Expanded Versatility and Increased Precision in the Treatment of Simple to...